How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials
Top Cited Papers
- 4 July 2005
- Vol. 331 (7512) , 313-321
- https://doi.org/10.1136/bmj.38503.623646.8f
Abstract
Objective To determine the effect of perioperative β blocker treatment in patients having non-cardiac surgery. Design Systematic review and meta-analysis. Data sources Seven search strategies, including searching two bibliographic databases and hand searching seven medical journals. Study selection and outcomes We included randomised controlled trials that evaluated β blocker treatment in patients having non-cardiac surgery. Perioperative outcomes within 30 days of surgery included total mortality, cardiovascular mortality, non-fatal myocardial infarction, non-fatal cardiac arrest, non-fatal stroke, congestive heart failure, hypotension needing treatment, bradycardia needing treatment, and bronchospasm. Results Twenty two trials that randomised a total of 2437 patients met the eligibility criteria. Perioperative β blockers did not show any statistically significant beneficial effects on any of the individual outcomes and the only nominally statistically significant beneficial relative risk was 0.44 (95% confidence interval 0.20 to 0.97, 99% confidence interval 0.16 to 1.24) for the composite outcome of cardiovascular mortality, non-fatal myocardial infarction, and non-fatal cardiac arrest. Methods adapted from formal interim monitoring boundaries applied to cumulative meta-analysis showed that the evidence failed, by a considerable degree, to meet standards for forgoing additional studies. The individual safety outcomes in patients treated with perioperative β blockers showed a relative risk for bradycardia needing treatment of 2.27 (95% CI 1.53 to 3.36, 99% CI 1.36 to 3.80) and a nominally statistically significant relative risk for hypotension needing treatment of 1.27 (95% CI 1.04 to 1.56, 99% CI 0.97 to 1.66). Conclusion The evidence that perioperative β blockers reduce major cardiovascular events is encouraging but too unreliable to allow definitive conclusions to be drawn.Keywords
This publication has 54 references indexed in Scilit:
- The effects of perioperative β-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trialAmerican Heart Journal, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular SurgeryNew England Journal of Medicine, 1999
- Reducing Cardiac Risk in Noncardiac SurgeryNew England Journal of Medicine, 1999
- Catecholamine and cortisol responses to lower extremity revascularizationCritical Care Medicine, 1995
- Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double-blind studyJournal of Clinical Anesthesia, 1989
- Attenuation of the hemodynamic responses to endotracheal intubation with preinduction intravenous labetalolJournal of Clinical Anesthesia, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A Technique of Laryngoscopy for Difficult IntubationAnesthesiology, 1986
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985